May 8, 2013 License application for ragweed allergy immunotherapy tablet accepted for review by FDA
May 3, 2013 Three-month interim report (Q1) 2013
Apr 30, 2013 Release of three-month interim report (Q1) 2013: Investor and analyst meeting and audio cast
Participants are requested to call in before 1.55 p.m. (CEST). International participants should call in on tel. +44 208 817 9301 and Danish participants should call in on tel. +45 70 26 50 40 or tel. + 45 70 27 90 09.
Dial-in details:Please call in before 12.55 p.m. (CET). Danish participants should call in on tel. +45 70 26 50 40 and international participants should call in on tel. +44 (0) 20 8817 9301
Jun 5, 2013 Jefferies 2013 Healthcare Conference, New York
Jun 11, 2013 Goldman Sachs 34th Annual Global Healthcare Conference, Los Angeles
Aug 14, 2013 Six-month interim report (Q2) 2013
Nov 8, 2013 Nine-month interim report (Q3) 2013